Combo (IMAGE)
Caption
This immunotherapy technique combines artificial antigen presenting cells (orange) with anti-PD-1 antibodies (yellow) to activate killer T cells (pink) and prevent tumor cells (brown) from damping that response.
Credit
Alyssa Kosmides and Randall Meyer, Johns Hopkins Medicine
Usage Restrictions
None
License
Licensed content